A bitter battle over the ‘orphan drug’ program leaves patients’ pocketbooks at risk
A prescription drug that helps Lore Wilkinson walk and talk despite a rare muscle disease cost her so little for more than a decade that she didn’t even use her insurance to pay for it. But now, her Medicare insurance is shelling out about $40,000 for a one-month supply of the drug, and she fears […]
The post A bitter battle over the ‘orphan drug’ program leaves patients’ pocketbooks at risk appeared first on Missouri Independent.
stLouIST